奥佳华(002614) - 2022 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2022 was ¥1,583,603,294.78, representing a decrease of 23.70% compared to the same period last year[5] - Net profit attributable to shareholders was ¥27,687,468.03, down 73.46% year-on-year[5] - Basic earnings per share decreased by 76.47% to ¥0.04[5] - Total operating revenue for Q1 2022 was CNY 1,583,603,294.78, a decrease of 23.7% compared to CNY 2,075,361,491.16 in the same period last year[23] - Net profit for Q1 2022 was CNY 24,220,336.23, a decline of 78.9% from CNY 115,290,795.53 in Q1 2021[24] Cash Flow - The net cash flow from operating activities was -¥27,887,419.95, an improvement of 72.48% compared to the previous year[5] - Cash flow from operating activities for Q1 2022 was negative CNY 27,887,419.95, an improvement from negative CNY 101,318,622.75 in Q1 2021[25] - The net cash flow from financing activities was ¥103,835,960.11, a significant increase of 1214.50% due to increased bill discounting financing[15] - The net cash flow from financing activities was 103,835,960.11, a significant improvement from -9,316,842.95 in the previous period[26] Assets and Liabilities - Total assets at the end of the reporting period were ¥9,060,340,153.31, a decrease of 2.21% from the end of the previous year[5] - Total current assets as of March 31, 2022, amount to ¥6,156,605,848.50, a decrease from ¥6,359,118,877.14 at the beginning of the year[20] - Total current liabilities as of March 31, 2022, are ¥3,314,625,513.35, compared to ¥3,549,510,922.96 at the beginning of the year[21] - Total liabilities as of Q1 2022 were CNY 3,927,217,641.09, a decrease from CNY 4,175,018,175.08 in the previous year[24] Shareholder Information - Total number of common shareholders at the end of the reporting period is 37,475[17] - The largest shareholder, Zou Jianhan, holds 20.23% of shares, totaling 127,620,000 shares, with 95,715,000 shares pledged[17] - The second-largest shareholder, Li Wuling, holds 17.82% of shares, totaling 112,420,091 shares[17] Investment and Expenses - Investment income rose by 39.54% to ¥43,313,092.10, attributed to increased forward foreign exchange settlement gains[12] - Research and development expenses for Q1 2022 were CNY 63,821,842.75, a decrease of 25.5% compared to CNY 85,665,731.60 in Q1 2021[24] - Sales expenses for Q1 2022 were CNY 269,927,260.75, down 13.0% from CNY 309,988,037.06 in Q1 2021[24] Other Financial Metrics - The company reported a 290.85% increase in fair value changes, amounting to ¥14,395,574.75, due to effective currency risk management[12] - The company experienced a 125.54% increase in credit impairment losses, totaling -¥12,940,520.58, due to higher provisions for receivables[12] - Other comprehensive income after tax for Q1 2022 was CNY 17,176,185.57, compared to negative CNY 26,946,117.00 in Q1 2021[25] - Total equity attributable to shareholders of the parent company was CNY 4,874,852,747.55, an increase from CNY 4,828,764,373.98 in the previous year[24]